In the first half of 2025, the Dila medical laboratory opened 22 new branches, increasing its number of locations to 260 throughout Ukraine.
According to Ivan Telichkun, the company’s director of strategic development, who spoke to Interfax-Ukraine, Dila has closed one branch since the start of the full-scale invasion, while the remaining 17 branches that were damaged have already been restored and are continuing to operate.
“Since the beginning of the invasion, 17 branches have been damaged and one has been closed in Nikopol. The other damaged branches have been completely restored and are once again serving customers,” he said.
Telichkun specified that Dila branches are currently operating in frontline areas, including Chernihiv, Shostka, Kharkiv, Pavlohrad, Mykolaiv, and Kryvyi Rih. In Shostka, Kharkiv, and Mykolaiv, they were opened during the full-scale invasion.
“Dila operates in cities and regions that are under frequent threat of missile or drone attacks. These are Odesa (Odesa, Izmail), Dnipro, Kryvyi Rih, Poltava, Kirovohrad, Sumy (Shostka), Kyiv, Kharkiv, and Mykolaiv,” he said.
Telichkun noted that Dila continues to expand its network of branches across Ukraine, focusing primarily on the needs of its clients.
“Among the new locations of Dila branches are not only central areas of cities, but also modern residential complexes, which today form separate communities with developed infrastructure. We plan to expand the network further,” he said.
Commenting on the dynamics of prices for laboratory tests, Telichkun noted that since the beginning of the year, prices for laboratory tests have been gradually increasing.
“The main reasons are the rising cost of reagents and consumables purchased in foreign currency, as well as changes in salaries to ensure market-level wages. Responding to external economic factors, including price adjustments, allows us to maintain our core principles of quality and accuracy in our research, which are the foundation of our customers’ trust. We plan to keep prices stable, provided the market situation remains stable,” he said.
As reported, in 2024, the Dila medical laboratory opened 14 partner branches and expanded its network to 238 branches. In addition, Dila performed 9.3 million tests for 1.3 million patients in 2024.
